Ziff Capital Partners seed investment in Corner Therapeutics

Health Care · United States · Undisclosed

Ziff Capital Partners provided seed funding backing Corner Therapeutics, which debuted its dendritic cell hyperactivation (hDC) immunotherapy platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in November 2022.